BRCA1 Associated RING Domain Protein 1 (BARD1)

[Edit]

BRCA1 Associated RING Domain Protein 1 (BARD1)
BARD1 interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, BARD1 shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. The BARD1 protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. BARD1 may be the target of oncogenic mutations in breast or ovarian cancer.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant BRCA1 Associated RING Domain Protein 1 (BARD1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to BRCA1 Associated RING Domain Protein 1 (BARD1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to BRCA1 Associated RING Domain Protein 1 (BARD1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for BRCA1 Associated RING Domain Protein 1 (BARD1) CLIA Kit Customized Service Offer
n/a ELISA Kit for BRCA1 Associated RING Domain Protein 1 (BARD1) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant BRCA1 Associated RING Domain Protein 1 (BARD1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to BRCA1 Associated RING Domain Protein 1 (BARD1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to BRCA1 Associated RING Domain Protein 1 (BARD1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for BRCA1 Associated RING Domain Protein 1 (BARD1) CLIA Kit Customized Service Offer
n/a ELISA Kit for BRCA1 Associated RING Domain Protein 1 (BARD1) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant BRCA1 Associated RING Domain Protein 1 (BARD1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to BRCA1 Associated RING Domain Protein 1 (BARD1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to BRCA1 Associated RING Domain Protein 1 (BARD1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for BRCA1 Associated RING Domain Protein 1 (BARD1) CLIA Kit Customized Service Offer
n/a ELISA Kit for BRCA1 Associated RING Domain Protein 1 (BARD1) ELISA Kit Customized Service Offer
  1. "Identification of a RING protein that can interact in vivo with the BRCA1 gene product."Nat. Genet. 14:430-440(1996) [PubMed] [Europe PMC] [Abstract]
  2. "Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers."Hum. Mol. Genet. 7:195-202(1998) [PubMed] [Europe PMC] [Abstract]
  3. "Oncogenic BARD1 isoforms expressed in gynecological cancers."Cancer Res. 67:11876-11885(2007) [PubMed] [Europe PMC] [Abstract]
  4. "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract]
  5. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  6. "Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1."J. Biol. Chem. 274:5659-5665(1999) [PubMed] [Europe PMC] [Abstract]
  7. "Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50."Science 285:1576-1579(1999) [PubMed] [Europe PMC] [Abstract]
  8. "The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin."J. Biol. Chem. 278:34743-34746(2003) [PubMed] [Europe PMC] [Abstract]
  9. "BRCA1:BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair."Hum. Mol. Genet. 13:807-817(2004) [PubMed] [Europe PMC] [Abstract]
  10. "CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response."Nat. Struct. Mol. Biol. 14:710-715(2007) [PubMed] [Europe PMC] [Abstract]
  11. "Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry."Proteomics 7:868-874(2007) [PubMed] [Europe PMC] [Abstract]
  12. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  13. "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
  14. "NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control."Genes Dev. 23:729-739(2009) [PubMed] [Europe PMC] [Abstract]
  15. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  16. "The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function."Mol. Cell. Biol. 30:2787-2798(2010) [PubMed] [Europe PMC] [Abstract]
  17. "Structure of a BRCA1-BARD1 heterodimeric RING-RING complex."Nat. Struct. Biol. 8:833-837(2001) [PubMed] [Europe PMC] [Abstract]
  18. "Crystal structure of the BARD1 BRCT domains."Biochemistry 46:7706-7712(2007) [PubMed] [Europe PMC] [Abstract]
  19. "The BARD1 C-terminal domain structure and interactions with polyadenylation factor CstF-50."Biochemistry 47:11446-11456(2008) [PubMed] [Europe PMC] [Abstract]
  20. "Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences."J. Biol. Chem. 283:21179-21186(2008) [PubMed] [Europe PMC] [Abstract]